Skip to main content

and
  1. No Access

    Chapter

    Acute Cyclosporine a Nephrotoxicity

    Experimental studies in rats have demonstrated that CyA causes tubular necrosis only when given at very high dosage. At a dosage of 20 mg/kg b.w./day proximal tubular changes are subtle and can be detected onl...

    V. E. Andreucci, G. Conte, M. Sabbatini, G. Fuiano in Current Therapy in Nephrology (1989)

  2. No Access

    Chapter

    Successfull Treatment with Bicarbonate Dialysis (BD) of Severe Lactic Acidosis in Phenformin Treated Patients on Dialytic Treatment (DT)

    Phenformin is a well recognized cause of lactic acidosis (1.2) : for this reason, the health authorities of many Countries have withdrawn this drug: for istance, in the U.S.A. this is not available since 1977....

    G. Fuiano, P. Imperatore, V. Sepe, R. Iandolo in Current Therapy in Nephrology (1989)

  3. No Access

    Chapter

    Effects of Cyclosporine a on Renal Function and Proteinuria in Patients with Nephrotic Syndrome after a Single Oral Administration

    Cyclosporine A (CyA) is probably the most important advance in the immunosuppressive management of transplants, reducing the incidence of acute rejections without relevant incidence of haematologic and infecti...

    G. Fuiano, P. Stanziale, M. Balletta, V. Sepe, G. Conte in Current Therapy in Nephrology (1989)

  4. No Access

    Chapter

    Is Tubulointerstitial Damage a Reliable Index for Predicting Renal Outcome in Primary Membranous Nephropathy?

    Interstitial changes are often observed in primary glomerular disease. However, the severity of these changes is not always mirrored by the glomerular involvement. Aim of this study is to evaluate if the prese...

    P. Stanziale, V. Sepe, M. M. Balletta, A. Esposito in Current Therapy in Nephrology (1989)

  5. No Access

    Chapter

    “Renal Functional Reserve” in Renal Transplant Patients on Cyclosporine Therapy

    The increase in glomerular filtration rate (GFR) due to afferent and efferent arterioles vasodilation induced by protein-load or aminoacids and/or dopamine is termed “Renal Functional Reserve” (R...

    A. Papa, G. Fuiano, M. A. Lotito, T. Rampino, G. Campolo in Current Therapy in Nephrology (1989)

  6. No Access

    Chapter

    Clinical Presentation of IgA Nephropathy in Southern Italy

    First discovered by Berger (1–2), primary IgA nephropathy has been recognized as a distinct glomerulonephritis and defined as a disease with prominent mesangial IgA deposits in the absence of clinical signs of...

    M. Balletta, G. Fuiano, P. Stanziale, M. Viscione in Current Therapy in Nephrology (1989)

  7. No Access

    Chapter

    Relation Between Gengival Overgrowth and Cyclosporin (CyA) Blood Levels in Renal Transplanted Patients

    Gengival hypertrophy has been associated with the use of several drugs (phenytoin, primidone, valproic acid, nifedipine, nicardipine et al). Recently also CyA has been reported to cause this side effect. The m...

    S Matarasso, E Vaia, V Bozzini, S Federico, A Papa in Current Therapy in Nephrology (1989)

  8. No Access

    Chapter

    A Case of Relapsing Renal Micropolyarteritis: A Possible Association with Assumption of non Steroidal Antiinflammatory Drugs (NSAID)

    The onset of renal micropolyarteritis has been associated with the administration of a number of drugs: penicillins, suiphonamides and phenytoin have been more frequently recorded. The relationship between NSA...

    P. Stanziale, G. Fuiano, M. M. Balletta in Drugs, Systemic Diseases, and the Kidney (1989)

  9. No Access

    Chapter

    Renal Presentation is Not a Relevant Factor in Predicting Renal Outcome in Patients with Systemic Lupus

    Lupus nephritis is the most important cause of death in patients with systemic lupus erythematous (1–4). For this reason, an early biologic and clinic evaluation could be of great prognostic rilevance.

    G. Fuiano, P. Stanziale, M. Viscione, V. Sepe, B. Guida in Current Therapy in Nephrology (1989)

  10. No Access

    Chapter

    Cyclosporine a Nephrotoxicity

    Despite the many studies performed both in humans and in experimental animals during the decade which has elapsed since the introduction of Cyclosporine A (CyA) into clinical practice, the mechanisms by which ...

    V. E. Andreucci, G. Fuiano in International Yearbook of Nephrology 1989 (1989)

  11. No Access

    Chapter

    Renal Hemodynamic Effects of Short-Term Therapy with Low Doses of Cyclosporine a in Humans with Intact Kidneys

    Extensive studies in humans and in laboratory animals on acute cyclosporine A (CsA) nephrotoxicity have demonstrated that the decrease of GFR induced by CsA is due to a direct, although reversible impairment o...

    M. Balletta, C. Libetta, M. Delfino in New Therapeutic Strategies in Nephrology (1991)

  12. No Access

    Chapter

    Modifications of Plasma Volume and ANF During Long-Term Administration of Cyclosporie

    It has been recently suggested that prolonged administration of Cyclosporine (CsA) may determine a reduction of plasma volume (PV), potentially responsible for the nephrotoxicity induced by the drug ([1]). Aim...

    M. Sabbatini, L. De Nicola, G. Sansone in New Therapeutic Strategies in Nephrology (1991)

  13. No Access

    Chapter

    Early Effects of Acute Obstruction of Biliary Duct in the Rat

    The effects of jaundice on renal function have been until now studied in experimental models after 10–14 days or more of common bile duct ligation (1): this time of obstruction was sufficient to induce not onl...

    G. Fuiano, V. Sepe, N. Comi, V. Bisesti in New Therapeutic Strategies in Nephrology (1991)

  14. No Access

    Chapter

    Urinary Tract Infections in Pregnancy

    Urinary tract infection (UTI) is a common problem, affecting an estimated 10% to 20% of women during their lifetime (1). Consequently, it is not surprising that UTI represents one of the most common complicati...

    G. Fuiano in Tubulo-Interstitial Nephropathies (1991)